CHAD Therapeutics, Inc.
| OTC Markets: CHADQ
CHAD Therapeutics, Inc. develops, produces, and markets respiratory care devices, which are designed to improve the efficiency of oxygen delivery systems for both home and hospital treatment of patients who require supplemental oxygen. It is focused on the development and commercialization of diagnostic and therapeutic devices. The company was founded in August 1982, and is headquartered in Naples, FL.